Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R G Werner

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Arzneimittel-Forschung|January 1, 1989
Meeting the regulatory requirements for pharmaceutical production of recombinant DNA derived productsR G Werner, H Langlouis-Gau
The Journal of Antibiotics|May 1, 1981
Directed biosynthesis of new indolmycinsR G Werner, A L Demain
Arzneimittel-Forschung|February 1, 1988
Fermentation with immobilized cell culturesR G Werner, W Merk, F Walz
Arzneimittel-Forschung|December 1, 1996
Monitoring the glycosylation pattern of recombinant interferon-omega with high-pH anion-exchange chromatography and capillary electrophoresisK Kopp, M Schlüter, R G Werner
Arzneimittel-Forschung|January 1, 1985
[6R-[(R)-2-[3-[2-(p-Aminosulfonyl)anilino-4-hydroxy-5- pyrimidinyl]ureido]-2-(4-hydroxyphenyl)acetamido]-penicillanic acid, sodium salt (VX-VC 43), a new broad-spectrum beta-lactam antibiotic. In vitro and in vivo antibiotic activity]U Lechner, K R Appel, R G Werner
Antimicrobial Agents and Chemotherapy|January 1, 1982
Derivatives of 4-dihydro-4-deoxy-4(R)-amino spectinomycin and their activity against susceptible and resistant Escherichia coli strainsR G Werner, U L Lechner, H Goeth
Biochemical and Biophysical Research Communications|August 14, 1978
Inhibition of protein synthesis by three erythromycin-derivativesR G Werner, H Teraoka, K H Nierhaus
Arzneimittel-Forschung|January 1, 1981
Inhibition of the synthesis of the TEM-type beta-lactamase by purine derivativesR G Werner, M Poetsch, A M Erne
Journal of Biotechnology|January 1, 1992
Safety and economic aspects of continuous mammalian cell cultureR G Werner, F Walz, W Noé, et al.
Arzneimittel-Forschung|January 1, 1985
Beta-lactamases from Bacteroides fragilis active against oximino-cephalosporinsR G Werner, K R Appel, A M Erne
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Arzneimittel-Forschung|January 1, 1989
Meeting the regulatory requirements for pharmaceutical production of recombinant DNA derived productsR G Werner, H Langlouis-Gau
The Journal of Antibiotics|May 1, 1981
Directed biosynthesis of new indolmycinsR G Werner, A L Demain
Arzneimittel-Forschung|February 1, 1988
Fermentation with immobilized cell culturesR G Werner, W Merk, F Walz
Arzneimittel-Forschung|December 1, 1996
Monitoring the glycosylation pattern of recombinant interferon-omega with high-pH anion-exchange chromatography and capillary electrophoresisK Kopp, M Schlüter, R G Werner
Arzneimittel-Forschung|January 1, 1985
[6R-[(R)-2-[3-[2-(p-Aminosulfonyl)anilino-4-hydroxy-5- pyrimidinyl]ureido]-2-(4-hydroxyphenyl)acetamido]-penicillanic acid, sodium salt (VX-VC 43), a new broad-spectrum beta-lactam antibiotic. In vitro and in vivo antibiotic activity]U Lechner, K R Appel, R G Werner
Antimicrobial Agents and Chemotherapy|January 1, 1982
Derivatives of 4-dihydro-4-deoxy-4(R)-amino spectinomycin and their activity against susceptible and resistant Escherichia coli strainsR G Werner, U L Lechner, H Goeth
Biochemical and Biophysical Research Communications|August 14, 1978
Inhibition of protein synthesis by three erythromycin-derivativesR G Werner, H Teraoka, K H Nierhaus
Arzneimittel-Forschung|January 1, 1981
Inhibition of the synthesis of the TEM-type beta-lactamase by purine derivativesR G Werner, M Poetsch, A M Erne
Journal of Biotechnology|January 1, 1992
Safety and economic aspects of continuous mammalian cell cultureR G Werner, F Walz, W Noé, et al.
Arzneimittel-Forschung|January 1, 1985
Beta-lactamases from Bacteroides fragilis active against oximino-cephalosporinsR G Werner, K R Appel, A M Erne
Pageof 5